In short. The cases that should end the conversation: active infection, a nose needing structural change, and a patient who has not settled the reversibility question.
Key points
- A clinician who says no is offering something a clinic that agrees to everything cannot: evidence that the assessment is real.
- The most useful outcome of a consultation may be learning that the concern cannot be reached by adding, and leaving without a plan rather than with one.
This site has argued throughout that the injectable route is a reasonable treatment for a specific kind of nose problem. It follows that there are patients for whom the honest answer is no, and those cases are worth naming plainly rather than leaving to be discovered at an assessment.
When the tissue is not ready
Active infection or inflammation in or near the nose is a reason to wait, including an active skin condition, a recent illness, dental work or a vaccination that has the immune system occupied. Pregnancy and breastfeeding are reasons to defer an elective treatment. A history of a delayed inflammatory reaction to an injectable, or of a granulomatous condition, is a reason for a specific conversation, because the risks that matter here are the ones those histories raise.
When the problem is the wrong kind
Anyone whose concern is that the nose is too large, too wide, too long or crooked should be told that the injectable route cannot help, and told it before any discussion of cost or scheduling. The same applies where breathing is part of the complaint, because that is a structural and medical question. And it applies where a patient cannot point to a specific place: a general dissatisfaction with the nose is usually a request for a different nose, and adding material produces a larger version of the one they have.
The refusal that is worth hearing
A clinician who says no is offering something a clinic that agrees to everything cannot: evidence that the assessment is real. The most useful outcome of a consultation may be learning that the concern cannot be reached by adding, and leaving without a plan rather than with one.
When the expectation is the problem
A patient who needs the result to last a stated period, or who cannot accept that a future operation may be wanted, is asking for an assurance the treatment cannot give. A patient who has not settled the reversibility question should be sent away to settle it, because the decision only works when it is made as though it were final. And a patient whose reason for treatment is an event three weeks away should be told that the settled shape is a month off.
Reasons to stop the consultation
- An active infection, an untreated skin condition, or a pregnancy or breastfeeding status that has not been discussed.
- A concern that requires the nose to become smaller, narrower or straighter rather than fuller anywhere.
- Anyone promising a guaranteed duration, a guaranteed appearance, or a result that can certainly be undone.
Being turned down is not a judgement about a person or about how they look. It is a statement about the direction of a treatment and the nature of a problem, and it is the most useful thing an assessment can produce. A patient who leaves with a clear no has saved themselves the sessions and the material that would otherwise have accumulated in a nose that never needed it.
Frequently asked questions
If a clinic refuses to treat me, should I get a second opinion?
Sometimes. A refusal based on active infection, an untreated medical problem or a concern that needs an operation is a clinical judgement worth taking seriously. A second opinion is reasonable where the reasoning was not explained, but the answer is unlikely to differ if the reason was sound.
Is a refusal a judgement about how I look?
No. It is almost always about the direction of the treatment rather than about the nose. A patient whose concern is that the nose is too large is not being told anything about their appearance, only that adding material cannot make a nose smaller.
What should I do if the answer is no?
Ask what the honest alternative is, and whether anything should be done about the concern at all. Often the answer is an operation, sometimes it is a different treatment on a different feature, and sometimes it is nothing, which is a legitimate recommendation rather than a dismissal.
Risks & Limitations
- The nose is one of the highest-risk areas on the face for material entering a blood vessel. It is uncommon, it is time-critical, and it is not predictable from the outside.
- The route adds material and cannot remove any. A hump, a wide bridge or a deviated septum is not changed by an injection at any number of sessions.
- Reversal is unreliable. An injected enzyme can break down some substance classes and not others, and it does not restore the shape you started with.
- Each session raises the baseline under the skin. Over years the material that has not yet cleared accumulates, and there is no clean way to take it back.
- Nodules, firmness and small lumps at the injection points, which are common in the first fortnight and usually soften, but do not always.
- Bruising, swelling, tenderness and occasionally a delayed inflammatory reaction, which may need assessment and treatment rather than patience.
- The effect does not last indefinitely, its duration cannot be predicted for one person, and the change is decided as though it were final.
When to Seek Care
- Pain that is severe, is out of proportion to the injection, or is getting worse rather than easing — contact the clinic immediately.
- Skin that has blanched and not recovered, or that has turned dusky, grey or mottled.
- Any change in vision, in any part of the field, however brief — seek emergency care immediately.
- Spreading redness, warmth, swelling, discharge or fever at or near an injection site.
- A firm lump that is growing or painful, appearing weeks or months after treatment.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.